Professional Documents
Culture Documents
The Diagnosis and Treatment of The Cervical Vertigo
The Diagnosis and Treatment of The Cervical Vertigo
Otology
http://dx.doi.org/10.3342/kjorl-hns.2015.58.3.177
ious causes, thus it is hard for medical doctors to determine the exact kind of dizziness in the
final diagnosis. Recently, cervical vertigo was reported from several vertigo cases. Cervical vertigo is defined as sensation of rotation, resulting from an alteration of the neck proprioceptive
afferents of the upper cervical spine. The aim of our study is to document the clinical features
and the treatment outcomes in vertigo patients with myofascial pain syndrome (MPS).
Subjects and MethodZZA total of 488 patients, excluding 18 patients who received other diagnosis, were examined to investigate the reasons for dizziness. We evaluated 34 patients, who
were diagnosed with cervical vertigo by questionnaire after MPS treatments. Clinical evaluations for cervical vertigo were performed on all subjects, and vestibular function tests were also
performed in patients with vertigo symptoms. All patients received a total of 4 treatments including trigger point injection, physical therapy or medication, and then followed up, respectively. The symptom changes of dizziness, patient satisfaction and cervical pain were checked
before and treatment 1, 2, 4 times by Visual Analogue Scale (VAS) score.
ResultsZZThere were significant improvement in the VAS score of dizziness, patient satisfaction and cervical pain after treatment for MPS.
ConclusionZZTreatment for MPS could improve dizziness in cervical vertigo with MPS patients, but further study is needed to clearly confirm the cervical vertigo with MPS for improvKorean J Otorhinolaryngol-Head Neck Surg 2015;58(3):177-81
ing patients quality of life.
Key WordsZZMyofacial pain syndromeTrigger pointVertigo.
. ,
. 20
.1)
(cervical vertigo) ,
, ,
.2)
Brandt Bronstein3) ,
(somatic nerve)
, ,
MPS
Temporalis muscle
Sternocleidomastoid muscle
, 2013 3 1 2014 2 28
542( 256,
286) .
36 506
, 18
,
, , ,
, ,
, , ,
. ,
34
, , Dix-Hallpike , Romberg
(TPI) 1
, tandem gait , ,
2 4 .
, , , ,
Korea; 1 3) 2
Brandt Bronstein3) ,
0.5% 5%
, , ,
(tender spot)
1, 2, 4
, (trig-
. 0
, 10
.5,6)
178
. VAS
. 10
0
. VAS
268
, 0, 10
34(7.0%), 5(1.0%),
3(0.6%), 22(4.5%)
.
SPSS 17.0
15, 3, 1,
test , , ,
13 .
unpaired t-test .
16, 2, 2,
9 ,
95% (p-value0.05)
test). , 4,
3 (Table 1).
Cases (male:female)
BPPV
268 (147:121)*
54.9
VN
098 (51:47)*
20.1
34( 19, 15
Menieres disease
058 (15:43)*
11.9
Cervical vertigo
034 (19:15)*
07.0
CVA
005 (2:3)*
01.0
. .
Infectious disease
003 (2:1)*
00.6
Others
022 (9:13)*
04.5
*p0.05, by Fishers exact test. BPPV: benign paroxysmal positional vertigo, VN: vestibular neuritis, CVA: cerebrovascular
accident
Age (M:F)
42.7 (42.5:43.4)*
23.55.6 (22.34.2:24.16.1)*
15.54.7 (14.95.4:15.93.1)*
02.71.1 (2.61.4:2.91.9)*
,
1
,
.
1
. 1
Table 3. The comparison between pretreatment VAS score and posttreatment VAS score checked at 1, 2, and 4 times after treatment
for vertigo, patients satisfaction and cervical pain (meanSD)
Variables
VAS score
Vertigo
Patients satisfaction
Pretreatment
8.461.30*
1.480.94*
Cervical pain
7.841.51*
Posttreatment (1st)
3.530.95*
7.511.51*
4.511.65*
Posttreatment (2nd)
2.960.84*
8.140.48*
3.150.95*
Posttreatment (4th)
1.941.15*
8.950.45*
2.861.12*
*p0.05, by Wilcoxon signed rank test. VAS: Visual Analogue Scale, SD: standard deviation
www.jkorl.org 179
.11)
.
Temporalis
03.4
Sternocleidomastoid
08.5
Cervical paraspinatus
33.4
Upper trapezius
41.1
Levater scapular
13.6
.12)
,
,
(30~45%).4,13)
5~40% .14)
41.1%.
33.4%. , ,
, ,
, (
41.1%, 33.4%)
. Bracher 11)
.
, ,
8,9)
.7)
. ,
, Brandt-Bronstein
(TPI),
, , ,
, 1 4 , 1, 2
, , ,
, 4
, ,
.
10)
Ryan Cope
, ,
, 3
180
REFERENCES
1) Stone HE. Vertigo: a practical approach. Emerg Med Australas 2004;
16(1):13-6.
2) Wrisley DM, Sparto PJ, Whitney SL, Furman JM. Cervicogenic
dizziness: a review of diagnosis and treatment. J Orthop Sports Phys
Ther 2000;30(12):755-66.
3) Brandt T, Bronstein AM. Cervical vertigo. J Neurol Neurosurg
Psychiatry 2001;71(1):8-12.
4) Travell DG, Simon SD. Myofascial pain and dysfunction. In: Simons
DG, Travell JG, Simons LS, editors. Travell & Simons Myofascial
Pain and Dysfunction: the Trigger Point Manual. 2nd ed. Baltimore:
Williams & Wilkins;1999. p.12-93.
5) Tough EA, White AR, Richards S, Campbell J. Variability of criteria
used to diagnose myofascial trigger point pain syndrome--evidence
from a review of the literature. Clin J Pain 2007;23(3):278-86.
www.jkorl.org 181